Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2348380
Max Phase: Preclinical
Molecular Formula: C24H46N2O5
Molecular Weight: 442.64
Molecule Type: Small molecule
Associated Items:
ID: ALA2348380
Max Phase: Preclinical
Molecular Formula: C24H46N2O5
Molecular Weight: 442.64
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)CC(=O)N(CCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)C1CCCCC1
Standard InChI: InChI=1S/C24H46N2O5/c1-24(2,3)15-21(29)26(18-11-7-6-8-12-18)14-10-5-4-9-13-25-16-20(28)23(31)22(30)19(25)17-27/h18-20,22-23,27-28,30-31H,4-17H2,1-3H3/t19-,20+,22-,23-/m1/s1
Standard InChI Key: LXVIWWDTUQYPOY-IRMYBRCSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 442.64 | Molecular Weight (Monoisotopic): 442.3407 | AlogP: 1.90 | #Rotatable Bonds: 10 |
Polar Surface Area: 104.47 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.90 | CX Basic pKa: 8.37 | CX LogP: 1.74 | CX LogD: 0.73 |
Aromatic Rings: 0 | Heavy Atoms: 31 | QED Weighted: 0.39 | Np Likeness Score: -0.04 |
1. Du Y, Ye H, Gill T, Wang L, Guo F, Cuconati A, Guo JT, Block TM, Chang J, Xu X.. (2013) N-Alkyldeoxynojirimycin derivatives with novel terminal tertiary amide substitution for treatment of bovine viral diarrhea virus (BVDV), Dengue, and Tacaribe virus infections., 23 (7): [PMID:23453839] [10.1016/j.bmcl.2013.01.108] |
Source(1):